Literature DB >> 15521012

Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice.

Hiroshi Itoh1, Seiji Naganuma, Naoki Takeda, Shiro Miyata, Shunro Uchinokura, Tsuyoshi Fukushima, Shuichiro Uchiyama, Hiroyuki Tanaka, Koki Nagaike, Takeshi Shimomura, Keiji Miyazawa, Gen Yamada, Naomi Kitamura, Masashi Koono, Hiroaki Kataoka.   

Abstract

BACKGROUND AND AIMS: Hepatocyte growth factor activator (HGFA) is a serum proteinase that specifically converts an inactive single-chain form of hepatocyte growth factor (HGF) into an active 2-chain form. HGFA is produced in its precursor form and then activated in injured tissues. To address the precise role of HGFA and to investigate the mechanisms of HGF activation in injured tissues, we generated mice deficient in HGFA.
METHODS: HGFA-deficient mice were generated using targeted gene disruption. The regenerating process of intestinal mucosa damaged by oral administration of dextran sodium sulfate (DSS) or by rectal administration of acetic acid was examined in both HGFA-deficient and control mice. HGF processing activity was analyzed using Western blotting and an HGF activation assay.
RESULTS: Homozygous mutant mice were viable and fertile without obvious abnormalities. When mice were treated with 3% DSS in drinking water for 6 days followed by distilled water without DSS, 72% of HGFA-deficient mice died through day 12 while 75% of control mice survived injury. Similar results were also observed in the acetic acid-induced intestinal injury; the survival rate was 36.6% in HGFA-deficient mice and 84.2% in control mice. In HGFA-deficient mice, the injured mucosa was not sufficiently covered by regenerated epithelium and the activation of HGF was impaired in the injured colon.
CONCLUSIONS: These results indicate that HGFA is required for repair of injured intestinal mucosa but is not essential for normal development during embryogenesis or after birth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521012     DOI: 10.1053/j.gastro.2004.08.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

1.  Hepatocyte growth factor stimulates the migration of gastric epithelial cells by altering the subcellular localization of the tight junction protein ZO-1.

Authors:  Yuichiro Nasu; Akio Ido; Shirou Tanoue; Shinichi Hashimoto; Fumisato Sasaki; Shuji Kanmura; Hitoshi Setoyama; Masatsugu Numata; Keita Funakawa; Akihiro Moriuchi; Hiroshi Fujita; Toshio Sakiyama; Hirofumi Uto; Makoto Oketani; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

2.  Nuclear translocation of H2RSP is impaired in regenerating intestinal epithelial cells of murine colitis model.

Authors:  Seiji Naganuma; Hiroshi Itoh; Shuichiro Uchiyama; Koki Nagaike; Hiroyuki Tanaka; Yutaka Akiyama; Kazuo Chijiiwa; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

3.  Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta.

Authors:  Hiroyuki Tanaka; Koki Nagaike; Naoki Takeda; Hiroshi Itoh; Kazuyo Kohama; Tsuyoshi Fukushima; Shiro Miyata; Shuichiro Uchiyama; Shunro Uchinokura; Takeshi Shimomura; Keiji Miyazawa; Naomi Kitamura; Gen Yamada; Hiroaki Kataoka
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.

Authors:  Yutaka Akiyama; Miyuki Nagai; Wataru Komaki; Kousuke Marutsuka; Yujiro Asada; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

5.  Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers.

Authors:  S Uchiyama; H Itoh; S Naganuma; K Nagaike; T Fukushima; H Tanaka; R Hamasuna; K Chijiiwa; H Kataoka
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

Review 6.  Diabetes and the Small Intestine.

Authors:  Jonathan Gotfried; Stephen Priest; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

7.  Protective Effects of an Oxovanadium(IV) Complex with N2O2 Chelating Thiosemicarbazone on Small Intestine Injury of STZ-Diabetic Rats.

Authors:  Sevim Tunali; Selda Gezginci-Oktayoglu; Sehnaz Bolkent; Ediz Coskun; Tulay Bal-Demirci; Bahri Ulkuseven; Refiye Yanardag
Journal:  Biol Trace Elem Res       Date:  2020-07-09       Impact factor: 3.738

8.  Expression of hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma and postoperative outcomes.

Authors:  Mayumi Funagayama; Kazuhiro Kondo; Kazuo Chijiiwa; Hiroaki Kataoka
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

9.  Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.

Authors:  Yukinori Yamagata; Susumu Aikou; Tsuyoshi Fukushima; Hiroaki Kataoka; Yasuyuki Seto; Hiroyasu Esumi; Michio Kaminishi; James R Goldenring; Sachiyo Nomura
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-11       Impact factor: 4.052

Review 10.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.